Search

everythinglearnresearchcommunity

for

Search:↓

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Mercury allergy linked to specific genes may contribute to burning mouth syndrome, and silicon might play a role in maintaining healthy hair.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

The DQB1*03 allele is linked to higher alopecia areata risk in Italians.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Genetic factors, skin barrier, immune function, and obesity influence risk of fungal skin infections.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Genetic factors affecting skin health and body weight may increase the risk of dermatophytosis.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

A genetic marker linked to a type of hair loss was found in most patients studied.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Somatostatin may help protect hair follicles from immune attacks.